|
Volumn 12, Issue 5, 2000, Pages 651-660
|
Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: Results of a multicenter phase II trial
c
CPRLab
(Netherlands)
|
Author keywords
Ferristene; Gadodiamide injection; MRI; Preoperative staging; Rectal carcinoma
|
Indexed keywords
CONTRAST MEDIUM;
FERRISTENE;
GADODIAMIDE;
SUPERPARAMAGNETIC IRON OXIDE;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DOUBLE BLIND PROCEDURE;
DRUG FORMULATION;
EDEMA;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMAGE ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 3 CLINICAL TRIAL;
PHOBIA;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEIVER OPERATING CHARACTERISTIC;
RECTUM CANCER;
SKIN MANIFESTATION;
VISCOSITY;
ADENOCARCINOMA;
ADMINISTRATION, RECTAL;
ADULT;
AGED;
BIOPSY, NEEDLE;
CHI-SQUARE DISTRIBUTION;
CONTRAST MEDIA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FERRIC COMPOUNDS;
GADOLINIUM DTPA;
HUMANS;
IMAGE PROCESSING, COMPUTER-ASSISTED;
INJECTIONS, INTRAVENOUS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PREOPERATIVE CARE;
PROBABILITY;
RECTAL NEOPLASMS;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
|
EID: 0033760239
PISSN: 10531807
EISSN: None
Source Type: Journal
DOI: 10.1002/1522-2586(200011)12:5<651::AID-JMRI1>3.0.CO;2-R Document Type: Article |
Times cited : (46)
|
References (25)
|